News | tctmd.com

In-Depth

See all

Feature

Funding the Future: How Industry Support for CV Trials Could Evolve

By Michael O'Riordan

Feature

Toppling Silos, Testing Tech, and Trimming Egos: How COVID-19 May Remake Medicine

By Shelley Wood

News • Interventional

EXTRACT-PE: Positive Results With Aspiration Thrombectomy for Submassive PE

By Todd Neale

January 15, 2021

EXTRACT-PE: Positive Results With Aspiration Thrombectomy for Submassive PE

News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

The test isn’t widely reimbursed, but cost analysis suggests it is “economically prudent,” say researchers.

By Michael O'Riordan

January 14, 2021

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

News

COVID-19: TCTMD’s Daily Dispatch for January 14

WHO officials visiting China catch COVID-19, new US variants, RAAS inhibitor support, immunity post-infection, and more.

By Todd Neale

January 14, 2021

COVID-19: TCTMD’s Daily Dispatch for January 14

News

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

Along with BRACE CORONA, there are now two RCTs showing no impact on outcomes when maintaining ACE inhibitors and ARBs.

By Todd Neale

January 13, 2021

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

Rox Heart Radio

Rox Heart Radio: Interventional Cardiology Journals in COVID-19

News • Interventional

Even Very Low Alcohol Consumption Ups AF Risk

A community-based study of more than 100,000 people provides “solid evidence,” editorialists say, but still leaves open questions.

By Caitlin E. Cox

January 13, 2021

Even Very Low Alcohol Consumption Ups AF Risk

News • Interventional

New Tool Helps Balance Bleeding and Thrombotic Risks After PCI

Researchers say their two models are being incorporated into a mobile application that should launch in the next few weeks.

By Yael L. Maxwell

January 13, 2021

New Tool Helps Balance Bleeding and Thrombotic Risks After PCI

News

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

Two studies reveal the pandemic’s impact on CV mortality in the US and a global drop in diagnostics that could spell future trouble.

By Michael O'Riordan

January 12, 2021

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

News • Interventional

FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited

Acknowledging the recent, reassuring SWEDEPAD data, the agency says it’s not yet ready to update its advice to doctors.

By L.A. McKeown

January 12, 2021

FDA Says Newer Paclitaxel Data Is ‘Comforting’ but Limited

Feature

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

Editors grappled with study volume and quality but wanted to publish something—ANYTHING—on the virus’s CV effects.

By Michael O'Riordan

January 11, 2021

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

News

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

From medication decisions to referral issues and costs, the committee focused on streamlining science and assistance.

By L.A. McKeown

January 11, 2021

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

News • Interventional

How to Resume Elective CV Interventions as COVID-19 Rages On

An EAPCI document offers advice on how to prioritize procedures and do them safely as the pandemic moves past its first wave.

By Caitlin E. Cox

January 11, 2021

How to Resume Elective CV Interventions as COVID-19 Rages On

See All News

Advertisement

In-Depth

Funding the Future: How Industry Support for CV Trials Could Evolve

Toppling Silos, Testing Tech, and Trimming Egos: How COVID-19 May Remake Medicine

EXTRACT-PE: Positive Results With Aspiration Thrombectomy for Submassive PE

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

COVID-19: TCTMD’s Daily Dispatch for January 14

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

Rox Heart Radio: Interventional Cardiology Journals in COVID-19

Even Very Low Alcohol Consumption Ups AF Risk

New Tool Helps Balance Bleeding and Thrombotic Risks After PCI

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

How to Resume Elective CV Interventions as COVID-19 Rages On

Advertisement

@tctmd

Conference Coverage

TVT Connect 2020

HRS 2020

SCAI 2020

Around the Web

Advertisement

Advertisement

In-Depth

Search News

Sign Up for Our Newsletter

Advertisement

@tctmd

Conference Coverage

Around the Web

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content